HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS REGISTER		Author Keyword(s) Vol Page [Advanced]

This Article Full Text Full Text (PDF) Submit a response Alert me when this article is cited Alert me when eLetters are posted Alert me if a correction is posted Citation Map Services Email this link to a friend Similar articles in this journal Similar articles in PubMed Add article to my folders Download to citation manager Request Permissions Citing Articles Citing Articles via Google Scholar Google Scholar Articles by Preiss, D. Articles by Sattar, N. Search for Related Content PubMed PubMed Citation Articles by Preiss, D. Articles by Sattar, N.

Metabolic syndrome, dysglycaemia and vascular disease: making sense of the evidence

¹ Glasgow Royal Infirmary, Scotland, UK
² University of Glasgow, Scotland, UK

Correspondence to:
Professor N Sattar, BHF GCRC, University of Glasgow, G12 8TA, UK; nsattar{at}clinmed.gla.ac.uk

ABSTRACT
" ‘Diagnosis’ of metabolic syndrome by any current criteria is not needed and adds little to clinical practice. Attention and resources should be focused on the major modifiable risk factors and more should be done to engender sustainable lifestyle changes in all with vascular disease"

Abbreviations: BP, blood pressure; EASD, European Association for the Study of Diabetes; ESC, European Society of Cardiology; FRS, Framingham Risk Score; HDL, high-density lipoprotein; HR, hazard ratio; IFG, impaired fasting glycaemia; IDF, International Diabetes Federation; IGT, impaired glucose tolerance; LDL, low-density lipoprotein; NCEP, National Cholesterol Education Panel; OGTT, oral glucose tolerance test